Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO
A US listing for the oncology specialist continues a bumper year for biotech IPOs.
Read Full Article
Pharma Tech
Roche’s Tecentriq snags FDA label expansion in type of colon cancer
Tecentriq is now the first immunotherapy indicated for dMMR colon cancer specifically, which is often linked to a higher risk of progression after surgery.
Read Full Article
Pharma Tech
Bio-Techne opens GMP small molecule facility in Bristol, UK
Life science tools and diagnostics provider Bio-Techne Corporation has opened a new manufacturing facility in Bristol, UK, dedicated to GMP grade small molecules.
Read Full Article
Express Pharma
Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings
The price control measure covers non-scheduled anti-cancer drugs and aims to reduce medicine prices by up to 70% The post Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings appeared first on Express Pharma.
Read Full Article
Pharma Tech
Biohaven partners with Ono in $100m IgG degrader deal
Biohaven has entered into an exclusive regional collaboration and licensing agreement worth up to $100m with Ono Pharmaceutical for its MoDE pan IgG degrader portfolio.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 10, 2026, 1:33 AM
Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobs
The investment will establish a site that combines drug manufacturing, research and development, quality testing and digital operations in Montgomery County.
ET Pharma
Oct 10, 2026, 1:22 AM
Pharma lobby sues Trump administration over most favored nation pricing
The GLOBE rule intends to set hospital drug prices for Medicare patients. Its final version was published last week on exactly how a "most favored nation" pricing system based on what is paid in a group of comparable countries would be integrated in the Medicare Part B program.
Pharma Tech
Oct 9, 2026, 3:02 PM
Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO
A US listing for the oncology specialist continues a bumper year for biotech IPOs.
PharmaShots
Oct 9, 2026, 12:30 PM
Vir Biotechnology Secures the US FDA Fast Track Designation for VIR-5500 to Treat Prostate Cancer
Shots: Ref: Businesswire | Image: Vir Biotech | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Vir Biotechnology Secures the US FDA Fast Track Designation for VIR-5500 to Treat Prostate Cancer appeared first on PharmaShots.
PharmaShots
Oct 9, 2026, 11:30 AM
BMS Reports P-III (EXCALIBER-RRMM) Trial Data on Zenbexus Combination for R/R Multiple Myeloma
Shots: Ref: Businesswire | Image: BMS | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BMS Reports P-III (EXCALIBER-RRMM) Trial Data on Zenbexus Combination for R/R Multiple Myeloma appeared first on PharmaShots.
Pharma Tech
Oct 9, 2026, 10:37 AM
Roche’s Tecentriq snags FDA label expansion in type of colon cancer
Tecentriq is now the first immunotherapy indicated for dMMR colon cancer specifically, which is often linked to a higher risk of progression after surgery.
News
Latest industry coverage
Google News
Oct 10, 2026, 9:15 PM
Health Care Roundup: Market Talk - WSJ
Health Care Roundup: Market Talk WSJ
Google News
Oct 10, 2026, 8:48 PM
Particle Engineering Takes Center Stage as Drug Formulation Science Enters Its Translational Era - Bioengineer.org
Particle Engineering Takes Center Stage as Drug Formulation Science Enters Its Translational Era Bioengineer.org
Google News
Oct 10, 2026, 7:35 PM
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH - The Globe and Mail
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH The Globe and Mail
Google News
Oct 10, 2026, 6:59 PM
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH - The Motley Fool
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH The Motley Fool
Google News
Oct 10, 2026, 6:43 PM
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw - The Economic Times
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw The Economic Times
Google News
Oct 10, 2026, 5:38 PM
Better Pharma ETF: iShares IHE vs. State Street XPH - The Globe and Mail
Better Pharma ETF: iShares IHE vs. State Street XPH The Globe and Mail
Google News
Oct 10, 2026, 5:25 PM
Better Pharma ETF: iShares IHE vs. State Street XPH - The Motley Fool
Better Pharma ETF: iShares IHE vs. State Street XPH The Motley Fool
Google News
Oct 10, 2026, 5:16 PM
Standards And Reagents Market To 2035: Biologics Demand Drives Expansion - News and Statistics - IndexBox
Standards And Reagents Market To 2035: Biologics Demand Drives Expansion - News and Statistics IndexBox
Google News
Oct 10, 2026, 4:39 PM
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Globe and Mail
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma The Globe and Mail
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer